| Literature DB >> 34433046 |
Veronique Fischer1, Damien Plassard2, Tao Ye2, Bernardo Reina-San-Martin1, Matthieu Stierle1, Laszlo Tora1, Didier Devys3.
Abstract
SAGA (Spt-Ada-Gcn5 acetyltransferase) and ATAC (Ada-two-A-containing) are two related coactivator complexes, sharing the same histone acetyltransferase (HAT) subunit. The HAT activities of SAGA and ATAC are required for metazoan development, but the role of these complexes in RNA polymerase II transcription is less understood. To determine whether SAGA and ATAC have redundant or specific functions, we compare the effects of HAT inactivation in each complex with that of inactivation of either SAGA or ATAC core subunits in mouse embryonic stem cells (ESCs). We show that core subunits of SAGA or ATAC are required for complex assembly and mouse ESC growth and self-renewal. Surprisingly, depletion of HAT module subunits causes a global decrease in histone H3K9 acetylation, but does not result in significant phenotypic or transcriptional defects. Thus, our results indicate that SAGA and ATAC are differentially required for self-renewal of mouse ESCs by regulating transcription through different pathways in a HAT-independent manner.Entities:
Keywords: 4sU labeling; ATAC; HAT-independent function; Pol II transcription; SAGA; coactivator complexes; histone acetyltransferase; mouse embryonic stem cells; newly synthesized RNA
Mesh:
Substances:
Year: 2021 PMID: 34433046 PMCID: PMC8430043 DOI: 10.1016/j.celrep.2021.109598
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1.Inactivation of the core module of SAGA alters mouse ESC proliferation and self-renewal
(A) The HAT modules incorporate within SAGA or ATAC through Tada2a or Tada2b, respectively.
(B) Western blot analyses of two independent Supt7l−/− and Supt7l cell lines compared with wild-type (WT) cells. gTubulin serves as loading control. *, unspecific bands.
(C) Mass spectrometry analyses of SAGA complexes purified from Supt7l−/−, Supt7l, Tada2b−/−, and WT cells. *, bait protein. Shared indicates subunits shared between SAGA and TFIID. norm., normalized; NSAF, normalized spectral abundance factor.
(D) Representative images of clonal assays of SAGA mutant cells cultured in FCS+LIF medium and stained by crystal violet.
(E) Alkaline phosphatase (AP) staining on clonal assays of SAGA mutant lines cultured in FCS+LIF+2i medium. Scale bar represents 100 μm.
(F) Quantification of AP staining as shown in (D). Numbers of AP+ and AP− colonies were normalized to the total number of colonies.
(G) Total mRNA levels of pluripotency factors in WT, Supt20h−/−, and Supt7l−/− cells, normalized to RNA polymerase III genes (Rpph1 and Rn7sk) and to WT cells. For (F) and (G), the statistical test performed is Wilcoxon rank-sum test with Benjamini-Hochberg correction for multiple testing. Error bars show mean ± standard deviation (SD) of at least 4 biological replicates, using at least two independent clones. Only statistically significant (<0.05) results are indicated. See also Figure S1.
Figure 2.The ATAC complex is required for mouse ESC survival
(A and B) Western blot analyses of protein extracts prepared from ESC lines expressing AID-Yeats2 or AID-Zzz3. Three Yeats2 clones (A) and four Zzz3 clones (B) were treated for 24 h with (+) or without (−) auxin (IAA). *, unspecific bands.
(C and D) ATAC was purified from nuclear extracts of WT, Yeats2, and Zzz3 cells treated for 24 h with IAA or not (DMSO) (C) or WT and Tada2a−/− cells (D) by using anti-Atac2 antibodies and peptide elution. Beads incubated without antibody (no AB) are shown as control.
(E) Clonal assays of ATAC mutant cell lines compared with WT cells in FCS+LIF medium and stained with crystal violet. AID cell lines were treated with either DMSO or IAA.
(F) Clonal assays of cell lines in FCS+LIF+2i medium and stained with AP. Scale bar represents 100 μm.
(G) Quantification of AP staining in clonal assays as shown in (E), normalized as in Figure 1F.
(H) mRNA levels of pluripotency factors in Yeats2 mutant and WT cells upon 24–72 h of IAA treatment were normalized as in Figure 1G. Statistical test performed is Wilcoxon rank-sum test with Benjamini-Hochberg correction for multiple testing for (G) and two-sided Wilcoxon-Mann- Whitney test for (H). Error bars show mean ± SD of at least 4 biological replicates, using at least two independent clones. Only statistically significant (<0.05) results are indicated. See also Figure S2.
Figure 3.Loss of the shared acetyltransferase activity of SAGA and ATAC does not affect proliferation or self-renewal of mouse ESCs
(A) Western blot analyses of protein extracts prepared from three Tada3 cell lines treated with (+) or without (−) IAA for 24 h. *, unspecific bands.
(B) Western blot analyses of histone H3 lysine 9 acetylation (H3K9ac) levels in extracts prepared from Tada2a−/−, Tada2b−/−, and Tada3 cells treated for 24 h with IAA. Control cells are either heterozygous Tada3 or WT cells. Tbp serves as loading control.
(C) Quantification of H3K9ac levels normalized to Ponceau staining. Error bars show mean ± SD of at least 4 biological replicates using at least two independent clones. Only statistically significant (p < 0.05) results are indicated. Statistical test performed is Wilcoxon rank-sum test with Benjamini-Hochberg correction for multiple testing.
(D and E) Clonal assays of Tada3 and WT cells cultured in FCS+LIF (D) or FCS+LIF+2i (E) medium treated with DMSO or IAA and stained with crystal violet (D) or AP (E). Scale bar represents 100 μm.
(F) Quantification of AP staining of clonal assays as shown in (D), normalized as in Figure 1F. Error bars show mean ± SD of 8 biological replicates. At least two independent clones were analyzed per cell line. Statistical test performed is two-sided Wilcoxon-Mann-Whitney test. No statistically significant (p < 0.05) differences were detected. See also Figure S3.
Figure 4.SAGA and ATAC regulate the expression of different sets of genes
(A) Genome browser view showing newly synthesized mRNA sequencing coverage of Sf3b3 and Cog4 in Supt7l−/−, Yeats2, and Zzz3 cell lines compared with WT cells. The top panel shows total RNA-seq coverage in WT cells. Blue arrows indicate transcription direction.
(B) MA plots showing log2 fold changes (log2 FCs) of newly synthesized mRNA levels in Supt7l−/−, Yeats2, and Zzz3 cell lines relative to WT cells against the mean of normalized reads. For each cell line, two independent clones were treated for 24 h with IAA. Numbers of significantly up- and downregulated genes are indicated. An adjusted p value of 0.05 and absolute log2 FC of 0.5 were used as thresholds for significantly affected genes.
(C) Correlation analyses of log2 FCs of newly synthesized mRNA between Supt7l−/−, Yeats2, and Zzz3 lines.
(D) Venn diagrams comparing overlaps of significantly downregulated genes between Supt7l−/−, Yeats2, and Zzz3 cells.
(E) Left, genome browser view showing newly synthesized mRNA sequencing coverage of Sf3b3 and Cog4 in WT and Tada3 cells treated with IAA for 24 h. Right, MA plot showing log2 FCs of newly synthesized mRNA levels in Tada3 cells relative to WT cells treated with IAA. See also Figure S4.
Figure 5.H3K9ac and chromatin accessibility are decreased at ATAC- and SAGA-dependent genes
(A) Representative images of western blot analyses of H3K9ac levels in extracts prepared from WT, Yeats2, Tada2a−/−+Tada2b−/−, Tada3, and Supt7l−/− cells. AID cells were treated for 24 h with IAA. Tbp serves as loading control.
(B) Quantification of H3K9ac levels normalized to Ponceau staining. Error bars show mean ± SD of at least 6 biological replicates using at least two independent clones.
(C) Heatmap representation of H3K9ac ChIP-seq coverage in WT, Yeats2, Tada2a−/−+Tada2b−/−, Tada3, and Supt7l−/− cells over promoter regions of 8,201 genes considered as expressed based on 4sU-seq. TSS, transcription start site.
(D) Violin plots showing log2 FC of H3K9ac ChIP-seq coverage at promoters between Yeats2 (top panels) or Supt7l−/− cells (bottom panels) and WT cells for either genes found significantly downregulated (red) or unchanged (gray, absolute log2 FC < 0.2 and an adjusted p value > 0.2) by 4sU-seq in either Yeats2 (left panels) or Supt7l−/− cells (right panels). Numbers of genes per category are indicated below each violin graphs.
(E) Violin plots showing log2 FC of ATAC-seq coverage at promoters for genes which were found either downregulated (red) or unchanged (gray) in the respective 4sU-seq experiments. Statistical test performed in (B) is Wilcoxon rank-sum test with Benjamini-Hochberg correction for multiple testing and in (D) and (E) is two-sided Welch t test. Only statistically significant results (p < 0.05) are indicated. See also Figure S5.
Figure 6.Gene categories preferentially regulated by SAGA and ATAC
(A) Gene set enrichment analyses (GSEAs) for Gene Ontology (GO) biological processes based on log2 FCs in newly synthesized RNA levels from Supt7l−/−, Yeats2, and Zzz3 cells relative to WT cells. Colored bars represent statistically significant terms (false discovery rate [FDR] < 0.05), while non-significant terms are represented in gray.
(B) Violin plots of log2 FCs comparing the distribution of expression changes of genes belonging to the GO categories “cytoplasmic translation” (73 genes) and “response to LIF” (98 genes) to unchanged genes (75 genes). Statistical test performed is ANOVA test. Only statistically significant results (p < 0.05) are indicated.
(C) Transcription-factor-binding sites from ChEA and Encode ChIP datasets enriched in genes significantly downregulated in Supt7l−/−, Yeats2, and Zzz3 cell lines as identified by Enrichr. Only the first five transcription factors with the highest odds ratio and adjusted p value < 0.05 are shown.
Figure 7.ATAC is required for the expression of translation-related genes
(A) Volcano plots representation of differential expression between Supt7l−/−, Yeats2, Zzz3, Tada3, and WT cells. Numbers of significantly misregulated genes are indicated. Ribosome protein genes (RPGs) are highlighted as blue dots.
(B) Heatmap showing log2 FCs observed for all RPGs in Supt7l−/−, Yeats2, Zzz3, and Tada3 cell lines.
(C) Intron-containing mRNA levels of three RPGs (Rps24, Rpl29, and Rps5) in Yeats2, Zzz3, and WT cells upon 2–24 h of IAA treatment were normalized as in Figure 1G. Error bars show SD of 4 biological replicates, using two independent clones. Statistical test performed is Wilcoxon rank-sum test with Benjamini-Hochberg correction for multiple testing.
(D) Heatmap showing log2 FCs observed for four transcription factors involved in the regulation of RPG expression in the indicated cell lines.
(E and F) Western blot analysis of Rpl29 protein levels in two independent Yeats2 and Zzz3 cell lines (E) or Supt7l−/− cell lines (F) compared with WT cells. γTubulin serves as loading control.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Rabbit polyclonal anti-Supt7l | Bethyl Laboratories | Cat#A302–803A; RRID:AB_10630265 |
| Mouse monoclonal anti-γTubulin | Sigma-Aldrich | Cat#T6557; RRID:AB_477584 |
| Rabbit polyclonal anti-Rpl29 | ThermoFisher Scientific | Cat#15799–1-AP; RRID:AB_2878187 |
| Rabbit polyclonal anti-histone H3 lysine 9 acetylation | Abcam | Cat#ab4441; RRID:AB_2118292 |
| Rabbit polyclonal anti-HA tag | Abcam | Cat#ab9110; RRID:AB_307019 |
| Mouse monoclonal anti-Wdr5 | Abcam | Cat#ab56919; RRID:AB_946146 |
| Mouse monoclonal anti-Tbp | In-house | 3TF1–3G3; |
| Rabbit polyclonal anti-Taf7 | In-house | 3475; |
| Mouse monoclonal anti-Taf10 | In-house | 6TA-2B11; |
| Mouse monoclonal anti-Taf12 | In-house | 22TA-2A1; |
| Rabbit polyclonal anti-Atxn7l3 | In-house | 2325; |
| Rabbit polyclonal anti-Supt3h | In-house | 3118; |
| Rabbit polyclonal anti-Gcn5 | In-house | 2676; |
| Mouse monoclonal anti-Gcn5 | In-house | 2GC-2C11; |
| Rabbit polyclonal anti-Tada3 | In-house | 2678; |
| Rabbit polyclonal anti-Sgf29 | In-house | 2461; |
| Rabbit polyclonal anti-Atac2 | In-house | 2734; |
| Rabbit polyclonal anti-Mbip | In-house | 2768; |
| Rabbit polyclonal anti-Zzz3 | In-house | 2616; |
| Chemicals, peptides, and recombinant proteins | ||
| Indole-3-acetic acid | Sigma-Aldrich | Cat#I3750 |
| 4-thiouridine | Glentham Life Sciences or abcam | Cat#GN6085 or Cat#ab143718 |
| 4-thiouracil | Sigma-Aldrich | Cat#440736 |
| EZ-link HPDP-biotin | ThermoFisher Scientific | Cat#21341 |
| Streptavidin protein coupled to HRP | ThermoFisher Scientific | Cat#21126 |
| Home-made Tn5E54K,L372P transposase | Plasmid provided by Dr. Kim Remans, EMBL Heidelberg, Germany |
|
| Critical commercial assays | ||
| Alkaline Phosphatase Kit | Vector Laboratories | Cat#SK-5100 |
| TURBO DNA- | ThermoFisher Scientific | Cat#AM1907 |
| μMACS magnetic beads and columns | Miltenyi Biotec | Cat#130–074–101 |
| RNeasy MinElute Cleanup Kit | QIAGEN | Cat#74204 |
| NucleoSpin Gel and PCR Clean-up kit | Macherey-Nagel | Cat#740609.50 |
| RiboPure™ RNA Purification Kit | ThermoFisher Scientific | Cat#AM1926 |
| TruSeq Stranded Total RNA LT Sample Prep Kit with Ribo-Zero Gold | Illumina | Cat#RS-122–2301 or Cat#RS-122–2302 |
| Ribo-Zero Gold rRNA (Yeast) | Illumina | Cat#MRZY1324 |
| MicroPlex Library Preparation kit v2 | Diagenode | Cat#C05010014 |
| SPRIselect beads | Beckman-Coulter | Cat#B23319 |
| AMPure XP beads | Beckman-Coulter | Cat#A63882 |
| Deposited data | ||
| Raw and analyzed data 4sU RNA-seq | This paper | GEO: GSE175905 |
| Raw and analyzed data ATAC-seq | This paper | GEO: GSE175905 |
| Raw and analyzed data H3K9ac ChIP-seq | This paper | GEO: GSE175905 |
| Mass spectrometry proteomics Taf10 IP | This paper | PRIDE: PXD027026 |
| Mass spectrometry proteomics Mbip and Zzz3 IP | This paper | PRIDE: PXD027026 |
| Original western blot images | This paper | Mendeley Data: |
| Experimental models: Cell lines | ||
| Mouse: ES E14tg2a.4 cells (129P2 genetic background) | BayGenomics | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| Mouse: | This study | N/A |
| ATCC | CRL-1963 | |
| Experimental models: Organisms/strains | ||
|
| N/A | |
|
| N/A | |
| Oligonucleotides | ||
| For sgRNA sequences, see | This paper | N/A |
| For primer sequences, see | This paper | N/A |
| Recombinant DNA | ||
| Plasmid: | This paper | N/A |
| Plasmid: Cas9-eGFP-sgRNA against | This paper | N/A |
| Plasmid: Cas9-eGFP-sgRNA against | This paper | N/A |
| Plasmid: Cas9-mCherry-sgRNA against | This paper | N/A |
| Plasmid: Cas9-eGFP-sgRNA against | This paper | N/A |
| Plasmid: Cas9-eGFP-sgRNA against | This paper | N/A |
| Plasmid: Cas9-eGFP-sgRNA against | This paper | N/A |
| Plasmid: Tir1-IRES-BirA-NeomycinR | This paper | N/A |
| Plasmid: Cas9-mCherry-sgRNA against N-ter of | This paper | N/A |
| Homologous Recombination Plasmid for N-ter AID-tagging of | This paper | N/A |
| Plasmid: Cas9-mCherry-sgRNA against N-ter of | This paper | N/A |
| Homologous Recombination Plasmid for N-ter AID-tagging of | This paper | N/A |
| Plasmid: Cas9-mCherry-sgRNA against N-ter of | This paper | N/A |
| Homologous Recombination Plasmid for N-ter AID-tagging of | This paper | N/A |
| Plasmid: Cas9-mCherry-sgRNA against C-ter of | This paper | N/A |
| Homologous Recombination Plasmid for C-ter AID-tagging of | This paper | N/A |
| Software and algorithms | ||
| Fiji |
|
|
| cutadapt |
|
|
| Bowtie2 |
|
|
| STAR |
|
|
| htseq-count |
|
|
| DESeq2 |
|
|
| Enrichr |
| |
| RTA | Illumina |
|
| bcl2fastq | Illumina |
|
| Encode ATAC-seq pipeline | ENCODE |
|
| MACS2 |
|
|
| Homer v4.11.1 |
|
|
| Bedtools |
|
|
| Enrichr |
|
|
| WebGestalt GEne SeT Analysis Toolkit |
|
|
| chromHMM datasets |
|
|
| ATACseqQC |
|
|
| Proteome Discoverer | ThermoFisher Scientific |
|
| FlowJo™ | Ashland; Becton, Dickinson and Company |
|